Stem cell injections for axial back pain: a systematic review of associated risks and complications with a case illustration of diffuse hyperplastic gliosis resulting in cauda equina syndrome.

IF 1.8 2区 社会学 Q1 LAW
Duke Law Journal Pub Date : 2019-09-06 Print Date: 2019-12-01 DOI:10.3171/2019.6.SPINE19594
Salah G Aoun, Valery Peinado Reyes, Tarek Y El Ahmadieh, Matthew Davies, Ankur R Patel, Vin Shen Ban, Aaron Plitt, Najib E El Tecle, Jessica R Moreno, Jack Raisanen, Carlos A Bagley
{"title":"Stem cell injections for axial back pain: a systematic review of associated risks and complications with a case illustration of diffuse hyperplastic gliosis resulting in cauda equina syndrome.","authors":"Salah G Aoun, Valery Peinado Reyes, Tarek Y El Ahmadieh, Matthew Davies, Ankur R Patel, Vin Shen Ban, Aaron Plitt, Najib E El Tecle, Jessica R Moreno, Jack Raisanen, Carlos A Bagley","doi":"10.3171/2019.6.SPINE19594","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Axial low-back pain is a disease of epidemic proportions that exerts a heavy global toll on the active workforce and results in more than half a trillion dollars in annual costs. Stem cell injections are being increasingly advertised as a restorative solution for various degenerative diseases and are becoming more affordable and attainable by the public. There have been multiple reports in the media of these injections being easily available abroad outside of clinical trials, but scientific evidence supporting them remains scarce. The authors present a case of a serious complication after a stem cell injection for back pain and provide a systematic review of the literature of the efficacy of this treatment as well as the associated risks and complications.</p><p><strong>Methods: </strong>A systematic review of the literature was performed using the PubMed, Google Scholar, and Scopus online electronic databases to identify articles reporting stem cell injections for axial back pain in accordance with the PRISMA guidelines. The primary focus was on outcomes and complications. A case of glial hyperplasia of the roots of the cauda equina directly related to stem cell injections performed abroad is also reported.</p><p><strong>Results: </strong>The authors identified 14 publications (including a total of 147 patients) that met the search criteria. Three of the articles presented data for the same patient population with different durations of follow-up and were thus analyzed as a single study, reducing the total number of studies to 12. In these 12 studies, follow-up periods ranged from 6 months to 6 years, with 50% having a follow-up period of 1 year or less. Most studies reported favorable outcomes, although 36% used subjective measures. There was a tendency for pain relief to wane after 6 months to 2 years, with patients seeking a surgical solution. Only 1 study was a randomized controlled trial (RCT).</p><p><strong>Conclusions: </strong>There are still insufficient data to support stem cell injections for back pain. Additional RCTs with long-term follow-up are necessary before statements can be made regarding the efficacy and safety.</p>","PeriodicalId":47625,"journal":{"name":"Duke Law Journal","volume":"45 1","pages":"906-913"},"PeriodicalIF":1.8000,"publicationDate":"2019-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Duke Law Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3171/2019.6.SPINE19594","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/12/1 0:00:00","PubModel":"Print","JCR":"Q1","JCRName":"LAW","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Axial low-back pain is a disease of epidemic proportions that exerts a heavy global toll on the active workforce and results in more than half a trillion dollars in annual costs. Stem cell injections are being increasingly advertised as a restorative solution for various degenerative diseases and are becoming more affordable and attainable by the public. There have been multiple reports in the media of these injections being easily available abroad outside of clinical trials, but scientific evidence supporting them remains scarce. The authors present a case of a serious complication after a stem cell injection for back pain and provide a systematic review of the literature of the efficacy of this treatment as well as the associated risks and complications.

Methods: A systematic review of the literature was performed using the PubMed, Google Scholar, and Scopus online electronic databases to identify articles reporting stem cell injections for axial back pain in accordance with the PRISMA guidelines. The primary focus was on outcomes and complications. A case of glial hyperplasia of the roots of the cauda equina directly related to stem cell injections performed abroad is also reported.

Results: The authors identified 14 publications (including a total of 147 patients) that met the search criteria. Three of the articles presented data for the same patient population with different durations of follow-up and were thus analyzed as a single study, reducing the total number of studies to 12. In these 12 studies, follow-up periods ranged from 6 months to 6 years, with 50% having a follow-up period of 1 year or less. Most studies reported favorable outcomes, although 36% used subjective measures. There was a tendency for pain relief to wane after 6 months to 2 years, with patients seeking a surgical solution. Only 1 study was a randomized controlled trial (RCT).

Conclusions: There are still insufficient data to support stem cell injections for back pain. Additional RCTs with long-term follow-up are necessary before statements can be made regarding the efficacy and safety.

干细胞注射治疗轴性背痛:对相关风险和并发症的系统回顾,以及弥漫性增生性胶质病导致马尾综合征的病例说明。
目的:轴性腰背痛是一种流行性疾病,在全球范围内对在职人员造成了严重的伤害,每年造成的损失超过 5 万亿美元。干细胞注射被越来越多地宣传为治疗各种退行性疾病的恢复性解决方案,而且越来越为公众所接受和负担得起。媒体曾多次报道,在临床试验之外,这些注射在国外也很容易获得,但支持它们的科学证据仍然很少。作者介绍了一例干细胞注射治疗背痛后出现严重并发症的病例,并对这种治疗方法的疗效以及相关风险和并发症的文献进行了系统回顾:方法:根据PRISMA指南,使用PubMed、Google Scholar和Scopus在线电子数据库对文献进行了系统回顾,以确定报道干细胞注射治疗轴性背痛的文章。主要重点是结果和并发症。此外,还报告了一例与国外干细胞注射直接相关的马尾神经根胶质增生病例:作者发现了14篇符合搜索标准的文献(共包括147名患者)。其中三篇文章提供了同一患者群体的数据,但随访时间不同,因此作为一项研究进行分析,从而将研究总数减少到12项。在这 12 项研究中,随访时间从 6 个月到 6 年不等,其中 50% 的随访时间为 1 年或更短。大多数研究报告了良好的疗效,但其中 36% 采用的是主观测量方法。6 个月至 2 年后,疼痛缓解有减弱的趋势,患者会寻求手术治疗。只有一项研究是随机对照试验(RCT):结论:目前仍没有足够数据支持干细胞注射治疗背痛。结论:目前还没有足够的数据支持干细胞注射治疗背痛,有必要进行更多的RCT研究,并进行长期随访,才能就其有效性和安全性做出结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
0
期刊介绍: The first issue of what was to become the Duke Law Journal was published in March 1951 as the Duke Bar Journal. Created to provide a medium for student expression, the Duke Bar Journal consisted entirely of student-written and student-edited work until 1953, when it began publishing faculty contributions. To reflect the inclusion of faculty scholarship, the Duke Bar Journal became the Duke Law Journal in 1957. In 1969, the Journal published its inaugural Administrative Law Symposium issue, a tradition that continues today. Volume 1 of the Duke Bar Journal spanned two issues and 259 pages. In 1959, the Journal grew to four issues and 649 pages, growing again in 1970 to six issues and 1263 pages. Today, the Duke Law Journal publishes eight issues per volume. Our staff is committed to the purpose set forth in our constitution: to publish legal writing of superior quality. We seek to publish a collection of outstanding scholarship from established legal writers, up-and-coming authors, and our own student editors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信